ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Biocon subsidiary gets USFDA nod for generic drug for chronic heart failure
Biotechnology firm Biocon said its subsidiary has received approval from the US health regulator to market a generic medication to treat chronic heart failure. Biocon Pharma has received approval of its ANDA for Sacubitril/Valsartan Tablets, in 24 mg/26 mg
Announcement as on 01 September 2024

Biocon unit gets USFDA nod for generic drug
Biocon Pharma has received approval of its ANDA for Sacubitril/Valsartan Tablets, in 24 mg/26 mg, 49 mg/51 mg and 97 mg/103 mg strengths, from the US Food and Drug Administration (USFDA), the company said in a regulatory filing. Sacubitril and valsartan co
Announcement as on 01 September 2024

Biocon settles with Janssen to commercialise biosimilar products in Europe, Canada, Japan
Biocon Biologics has entered into a settlement and licence agreement with Janssen Biotech Inc, Janssen Sciences Ireland, and Johnson & Johnson to launch Bmab 1200, a biosimilar to Stelara, in Europe, the UK, Canada, and Japan. This deal resolves patent
Announcement as on 29 August 2024

Biocon inks pact with Janssen to commercialise biosimilar products in Japan
Biocon Biologics on Thursday said it has inked a pact with Janssen for launching a biosimilar medication for the treatment of autoimmune diseases in Europe, the United Kingdom, Canada, and Japan. The company, a subsidiary of Biocon Ltd, has inked a settlem
Announcement as on 29 August 2024

Biocon Biologics secures deal with Janssen to launch biosimilar Bmab 1200
Agreement clears way for Indian company to launch treatment in Europe, Canada and other markets
Announcement as on 29 August 2024

Announcements by Biocon Ltd. first page | Next page | Prev page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 391.11
  • 12Day Average: 393.85
  • 20Day Average: 390.45
  • 50Day Average: 390.62
  • 100Day Average: 373.43
  • 150Day Average: 370.8
  • 200Day Average: 361.18

532523 Indicators & signals

Indicator MACD (12,26,9)

392.5, 391.8, 1.15
Indicator MACD is in positive zone

Indicator ADX (14)

6.54, 20.43, 17.92
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 43
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Fri Jan 2026 393.25 386.45 to 394.65 1.42% 0.47 times
01 Thu Jan 2026 387.75 386.00 to 393.70 -1.56% 0.43 times
31 Wed Dec 2025 393.90 388.20 to 394.90 0.9% 0.71 times
30 Tue Dec 2025 390.40 389.60 to 392.80 0.04% 0.76 times
29 Mon Dec 2025 390.25 388.15 to 399.30 -1.27% 0.43 times
26 Fri Dec 2025 395.25 394.05 to 401.00 -0.7% 0.34 times
24 Wed Dec 2025 398.05 397.30 to 406.00 -0.83% 0.79 times
23 Tue Dec 2025 401.40 398.85 to 403.70 0.59% 0.81 times
22 Mon Dec 2025 399.05 397.15 to 402.80 0.18% 3.69 times
19 Fri Dec 2025 398.35 393.50 to 401.55 1.58% 0.98 times
18 Thu Dec 2025 392.15 385.80 to 395.35 1.49% 1.06 times
17 Wed Dec 2025 386.40 383.90 to 388.50 0.45% 0.2 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top